These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 33152028)

  • 1. Quantifying cognitive resilience in Alzheimer's Disease: The Alzheimer's Disease Cognitive Resilience Score.
    Yao T; Sweeney E; Nagorski J; Shulman JM; Allen GI
    PLoS One; 2020; 15(11):e0241707. PubMed ID: 33152028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural substrates of cognitive reserve in Alzheimer's disease spectrum and normal aging.
    Lee DH; Lee P; Seo SW; Roh JH; Oh M; Oh JS; Oh SJ; Kim JS; Jeong Y
    Neuroimage; 2019 Feb; 186():690-702. PubMed ID: 30503934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using high-dimensional machine learning methods to estimate an anatomical risk factor for Alzheimer's disease across imaging databases.
    Casanova R; Barnard RT; Gaussoin SA; Saldana S; Hayden KM; Manson JE; Wallace RB; Rapp SR; Resnick SM; Espeland MA; Chen JC;
    Neuroimage; 2018 Dec; 183():401-411. PubMed ID: 30130645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying longitudinal cognitive resilience to Alzheimer's disease and other neuropathologies.
    Wagner M; Wilson RS; Leurgans SE; Boyle PA; Bennett DA; Grodstein F; Capuano AW
    Alzheimers Dement; 2022 Nov; 18(11):2252-2261. PubMed ID: 35102704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive composite score association with Alzheimer's disease plaque and tangle pathology.
    Malek-Ahmadi M; Chen K; Perez SE; He A; Mufson EJ
    Alzheimers Res Ther; 2018 Sep; 10(1):90. PubMed ID: 30205840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of Cognitive Impairment Compatible with Early Diagnosis of Alzheimer's Disease. A Bayesian Network Model based on the Analysis of Oral Definitions of Semantic Categories.
    Guerrero JM; Martínez-Tomás R; Rincón M; Peraita H
    Methods Inf Med; 2016; 55(1):42-9. PubMed ID: 25925692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive function and neuropathological outcomes: a forward-looking approach.
    Munoz E; Filshtein T; Bettcher BM; McLaren D; Hedden T; Tommet D; Mungas D; Therneau T
    J Neurol; 2019 Dec; 266(12):2920-2928. PubMed ID: 31435771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Models Based on Non-Cognitive Measures May Identify Presymptomatic Alzheimer's Disease.
    Yang J; Oveisgharan S; Liu X; Wilson RS; Bennett DA; Buchman AS
    J Alzheimers Dis; 2022; 89(4):1249-1262. PubMed ID: 35988224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining Cognitive Reserve and Implications for Cognitive Aging.
    Pettigrew C; Soldan A
    Curr Neurol Neurosci Rep; 2019 Jan; 19(1):1. PubMed ID: 30627880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
    Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
    J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network-Based Substrate of Cognitive Reserve in Alzheimer's Disease.
    Serra L; Mancini M; Cercignani M; Di Domenico C; Spanò B; Giulietti G; Koch G; Marra C; Bozzali M
    J Alzheimers Dis; 2017; 55(1):421-430. PubMed ID: 27662319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer's disease.
    Soldan A; Pettigrew C; Cai Q; Wang J; Wang MC; Moghekar A; Miller MI; Albert M;
    Neurobiol Aging; 2017 Dec; 60():164-172. PubMed ID: 28968586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative estimate of cognitive resilience and its medical and genetic associations.
    Phongpreecha T; Godrich D; Berson E; Espinosa C; Kim Y; Cholerton B; Chang AL; Mataraso S; Bukhari SA; Perna A; Yakabi K; Montine KS; Poston KL; Mormino E; White L; Beecham G; Aghaeepour N; Montine TJ
    Alzheimers Res Ther; 2023 Nov; 15(1):192. PubMed ID: 37926851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
    Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Progression From Mild Cognitive Impairment to Alzheimer's Disease Using Autoregressive Modelling of Longitudinal and Multimodal Biomarkers.
    Minhas S; Khanum A; Riaz F; Khan SA; Alvi A
    IEEE J Biomed Health Inform; 2018 May; 22(3):818-825. PubMed ID: 28534796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lap Time Variability From a 400-m Walk Is Associated With Future Mild Cognitive Impairment and Alzheimer's Disease.
    Tian Q; Resnick SM; Studenski SA; Ferrucci L
    J Am Med Dir Assoc; 2019 Dec; 20(12):1535-1539.e3. PubMed ID: 31227471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.
    Soldan A; Pettigrew C; Lu Y; Wang MC; Selnes O; Albert M; Brown T; Ratnanather JT; Younes L; Miller MI;
    Hum Brain Mapp; 2015 Jul; 36(7):2826-41. PubMed ID: 25879865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.